Literature DB >> 23997357

Functional imaging of primary insomnia: new images and fresh opportunities.

Michael W L Chee.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23997357      PMCID： PMC3738033          DOI： 10.5665/sleep.2940

Source DB:  PubMed          Journal:  Sleep        ISSN： 0161-8105            Impact factor:   5.849


× No keyword cloud information.
  26 in total

1.  Functional neuroimaging evidence for hyperarousal in insomnia.

Authors:  Eric A Nofzinger; Daniel J Buysse; Anne Germain; Julie C Price; Jean M Miewald; David J Kupfer
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

Review 2.  Components of verbal working memory: evidence from neuroimaging.

Authors:  E E Smith; J Jonides; C Marshuetz; R A Koeppe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 3.  The role of default network deactivation in cognition and disease.

Authors:  Alan Anticevic; Michael W Cole; John D Murray; Philip R Corlett; Xiao-Jing Wang; John H Krystal
Journal:  Trends Cogn Sci       Date:  2012-11-08       Impact factor: 20.229

Review 4.  Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza; Duanping Liao; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2013-02-16       Impact factor: 11.609

Review 5.  Searching for the daytime impairments of primary insomnia.

Authors:  Julia A Shekleton; Naomi L Rogers; Shantha M W Rajaratnam
Journal:  Sleep Med Rev       Date:  2009-12-05       Impact factor: 11.609

Review 6.  Hyperarousal and insomnia: state of the science.

Authors:  Michael H Bonnet; Donna L Arand
Journal:  Sleep Med Rev       Date:  2009-07-28       Impact factor: 11.609

Review 7.  The hyperarousal model of insomnia: a review of the concept and its evidence.

Authors:  Dieter Riemann; Kai Spiegelhalder; Bernd Feige; Ulrich Voderholzer; Mathias Berger; Michael Perlis; Christoph Nissen
Journal:  Sleep Med Rev       Date:  2009-05-28       Impact factor: 11.609

8.  Cerebral perfusion and oxygenation differences in Alzheimer's disease risk.

Authors:  Adam S Fleisher; Katherine M Podraza; Katherine J Bangen; Curtis Taylor; Ayesha Sherzai; Kunal Sidhar; Thomas T Liu; Anders M Dale; Richard B Buxton
Journal:  Neurobiol Aging       Date:  2008-03-05       Impact factor: 4.673

9.  Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia.

Authors:  Susan Whitfield-Gabrieli; Heidi W Thermenos; Snezana Milanovic; Ming T Tsuang; Stephen V Faraone; Robert W McCarley; Martha E Shenton; Alan I Green; Alfonso Nieto-Castanon; Peter LaViolette; Joanne Wojcik; John D E Gabrieli; Larry J Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

10.  On the Need of Objective Vigilance Monitoring: Effects of Sleep Loss on Target Detection and Task-Negative Activity Using Combined EEG/fMRI.

Authors:  Michael Czisch; Renate Wehrle; Helga A Harsay; Thomas C Wetter; Florian Holsboer; Philipp G Sämann; Sean P A Drummond
Journal:  Front Neurol       Date:  2012-04-27       Impact factor: 4.003
View more
  3 in total

1.  Temporal regularity of intrinsic cerebral activity in patients with chronic primary insomnia: a brain entropy study using resting-state fMRI.

Authors:  Fuqing Zhou; Suhua Huang; Lei Gao; Ying Zhuang; Shan Ding; Honghan Gong
Journal:  Brain Behav       Date:  2016-07-14       Impact factor: 2.708

2.  Disrupted interhemispheric functional connectivity in chronic insomnia disorder: a resting-state fMRI study.

Authors:  Fuqing Zhou; Yanlin Zhao; Muhua Huang; Xianjun Zeng; Bo Wang; Honghan Gong
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-14       Impact factor: 2.570

Review 3.  Migraine Is More Than Just Headache: Is the Link to Chronic Fatigue and Mood Disorders Simply Due to Shared Biological Systems?

Authors:  Nazia Karsan; Peter J Goadsby
Journal:  Front Hum Neurosci       Date:  2021-06-03       Impact factor: 3.169
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.